Investor Relation Menu

• IR Home
• Corporate Info
  • Chairman's Statement
  • Values and Brand Promise
  • Board Of Directors
  • Key Management
• Our Business Units
• Financial Info
  • Financials
  • Annual Reports
  • Sustainability Report
• Newsroom
  • Announcements
  • Press Releases
• Stock Info
• Info Request
  • Email Alerts
  • IR Contact

News

Change - Announcement Of Cessation Of Group Financial Controller

BackAug 14, 2024

Announcement Title	Change - Announcement of Cessation
Date & Time of Broadcast	Aug 14, 2024 18:03
Status	New
Announcement Sub Title	CESSATION OF GROUP FINANCIAL CONTROLLER
Announcement Reference	SG240814OTHRJ8EU
Submitted By (Co./ Ind. Name)	Stanley Woo
Designation	Group Financial Controller
Description (Please provide a detailed description of the event in the box below)	Sponsor statement: This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd. It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 63194954.
Additional Details
Name Of Person	Stanley Woo Ah Toong
Age	61
Is effective date of cessation known?	Yes
If yes, please provide the date	01/09/2024
Detailed Reason (s) for cessation	Mr Woo will relinquish his role as Group Financial Controller ("GFC") on 1 September 2024 due to personal reasons. He will take up a new role as Senior Finance Manager on 2 September 2024 and will primarily focus on AsiaMedic Sunway Pte. Ltd., the Group's new diagnostic imaging company. The Company's Sponsor has interviewed Mr Woo and is satisfied, other than the reason as disclosed above, there are no material reasons for his cessation as GFC.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?	No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?	No
Any other relevant information to be provided to shareholders of the listed issuer?	No
Date of Appointment to current position	11/05/2009
Does the AC have a minimum of 3 members (taking into account this cessation)?	Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)	2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months	1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)	Group Financial Controller
Role and responsibilities	Mr Woo is responsible for the Group's accounting, financial, taxation and other corporate compliance matters.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries	No
Shareholding interest in the listed issuer and its subsidiaries?	Yes
Shareholding Details	100,000 ordinary shares in AsiaMedic Limited
Past (for the last 5 years)	AsiaMedic Heart & Vascular Centre Pte. Ltd.
Present	The Orchard Imaging Centre Pte. Ltd. AsiaMedic Wellness Assessment Centre Pte. Ltd AsiaMedic PET/CT Centre Pte. Ltd. Complete Healthcare International Pte. Ltd. AsiaMedic Astique The Aesthetic Clinic Pte. Ltd. AMC Healthcare Pte. Ltd. AsiaMedic Eye Centre Pte. Ltd. Positron Tracers Pte. Ltd.